特奈特普酶
医学
溶栓
改良兰金量表
冲程(发动机)
纤溶剂
析因分析
组织纤溶酶原激活剂
内科学
心肌梗塞
缺血性中风
缺血
机械工程
工程类
作者
Radhika Nair,Nishita Singh,Mahesh Kate,Negar Asdaghi,Robert Joseph Sarmiento,Fouzi Bala,Shelagh B. Coutts,MacKenzie Horn,Alexandre Y. Poppe,Heather Williams,Ayoola Ademola,Ibrahim Alhabli,Faysal Benali,Houman Khosravani,Gary R. Hunter,Aleksander Tkach,Herbert Alejandro Manosalva Alzate,Aleksandra Pikula,Thalia S. Field,Anurag Trivedi
标识
DOI:10.1136/svn-2023-002828
摘要
In this post-hoc analysis of patients with minor stroke enrolled in the AcT trial, safety and efficacy outcomes with tenecteplase 0.25 mg/kg were not different from alteplase 0.9 mg/kg.
科研通智能强力驱动
Strongly Powered by AbleSci AI